We can help you find what you need. Get in touch with us.
There are few companies in the pharmaceutical industry that are not experiencing decreased revenue and profitability. At the same time, the costs associated with developing a new drug and bringing it to market continues to grow. In order to increase ....
Others | Apr 15th, 2009 | by CBR Pharma Insights
Industry : Healthcare
Due to decreasing sales growth, the pharmaceutical industry as a whole has seen a steady decline in consumer marketing budgets. At the same time, it has experienced an increase in both competition from generics and oversight by the FDA. Mass media....
Others | Apr 15th, 2009 | by CBR Pharma Insights
Industry : Healthcare
Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. Recent trends indicate a consolidation of efforts through numerous acquisitions, both intra-phar....
Others | Apr 15th, 2009 | by CBR Pharma Insights
Industry : Healthcare
The nature of biotechnology has, up until recently, prevented the threat of generic intrusion on product sales. Biologics are difficult to replicate compared to small molecules and even slight differences in manufacturing processes could lead to sign....
Others | Jun 15th, 2009 | by CBR Pharma Insights
Industry : Healthcare
President Obama has made healthcare reform one of his administrations top priorities. Towards this goal, several billion dollars have been provided through the Recovery Act and 2010 Budget for initiatives that are intended to make the US healthcare s....
Others | Jun 15th, 2009 | by CBR Pharma Insights
Industry : Healthcare